Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at a price of not more than CNY 16 per share.

The shares purchased will be used for the company's equity incentive plan or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.